SAN FRANCISCO, July 22, 2024 /PRNewswire/ -- Invitae (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure ® program, which provides accessible ...
SAN FRANCISCO, Feb. 26, 2019 /PRNewswire/ -- As Rare Disease Day focuses attention on the challenges of diagnosing rare, often genetic conditions, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Invitae ...
Invitae (NYSE:NVTA) will collaborate with Pacific Biosciences of California (NASDAQ:PACB) to develop whole genome sequencing-based assays for pediatric epilepsy. The first phase of the research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback